RenovoRx enters $3.7M ATM equity sales agreement with JonesTrading

RenovoRx, Inc.

Up to $3,723,029 in common stock may be sold at-the-market through JonesTrading; 3.0% commission.
Shares issued under effective shelf registration S-3 (333-268302) and new prospectus supplement filed Nov 14, 2025.
Company also filed new S-3 to extend current shelf's usability for 180 days past Nov 21, 2025 expiration.
No assurances any shares will be issued; company reimburses agent specified expenses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.